CCAAT/enhancer binding protein δ regulates glial proinflammatory gene expression

Neurobiology of Aging

Volumn 34, Issue 9, 2013, Pages 2110-2124

  Valente, Tony ^a,b   Straccia, Marco ^a,b   Gresa Arribas, Nuria ^a,b   Dentesano, Guido ^a,b   Tusell, Josep M ^b   Serratosa, Joan ^b   Mancera, Pilar ^b   Solà, Carme ^b   Saura, Josep ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Amyotrophic lateral sclerosis; C EBPdelta; Lipopolysaccharide; Microglia; Neuroinflammation; Transcription factors

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; CYCLOOXYGENASE 2; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CCAAT ENHANCER BINDING PROTEIN DELTA GENE; CELL ACTIVATION; CELL PHAGOCYTOSIS; COCULTURE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERLEUKIN 1BETA GENE; INTERLEUKIN 6 GENE; MALE; MICROGLIA; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NITRIC OXIDE SYNTHASE 2 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TUMOR NECROSIS FACTOR ALPHA GENE; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELLS, CULTURED; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; MICE; MICROGLIA; MOLECULAR TARGETED THERAPY; NEUROGENIC INFLAMMATION; NITRIC OXIDE SYNTHASE TYPE II; SUPEROXIDE DISMUTASE;

EID: 84878940539     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.02.007     Document Type: Article

References (59)

1. Alam T., An M.R., Papaconstantinou J. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J.Biol. Chem. 1992, 267:5021-5024.
2. Banks W.A., Robinson S.M. Minimal penetration of lipopolysaccharide across the murine blood-brain barrier. Brain Behav. Immun. 2010, 24:102-109.
3. Blatteis C.M. The onset of fever: new insights into its mechanism. Prog. Brain Res. 2007, 162:3-14.
4. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
5. Cardinaux J.R., Allaman I., Magistretti P.J. Pro-inflammatory cytokines induce the transcription factors C/EBPbeta and C/EBPdelta in astrocytes. Glia 2000, 29:91-97.
6. Cardinaux J.R., Magistretti P.J. Vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, and noradrenaline induce the transcription factors CCAAT/enhancer binding protein (C/EBP)-beta and C/EBP delta in mouse cortical astrocytes: involvement in cAMP-regulated glycogen metabolism. J.Neurosci. 1996, 16:919-929.
7. Colangelo V., Schurr J., Ball M.J., Pelaez R.P., Bazan N.G., Lukiw W.J. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J.Neurosci. Res. 2002, 70:462-473.
8. Dauffy J., Mouchiroud G., Bourette R.P. The interferon-inducible gene, Ifi204, is transcriptionally activated in response to M-CSF, and its expression favors macrophage differentiation in myeloid progenitor cells. J.Leukoc. Biol. 2006, 79:173-183.
9. Drew P.D., Xu J., Storer P.D., Chavis J.A., Racke M.K. Peroxisome proliferator-activated receptor agonist regulation of glial activation: relevance to CNS inflammatory disorders. Neurochem. Int. 2006, 49:183-189.
10. Ejarque-Ortiz A., Gresa-Arribas N., Straccia M., Mancera P., Sola C., Tusell J.M., Serratosa J., Saura J. CCAAT/enhancer binding protein delta in microglial activation. J.Neurosci. Res. 2010, 88:1113-1123.
11. Ejarque-Ortiz A., Medina M.G., Tusell J.M., Perez-Gonzalez A.P., Serratosa J., Saura J. Upregulation of CCAAT/enhancer binding protein beta in activated astrocytes and microglia. Glia 2007, 55:178-188.
12. Evert B.O., Schelhaas J., Fleischer H., de Vos R.A., Brunt E.R., Stenzel W., Klockgether T., Wullner U. Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3. Clin. Neuropathol. 2006, 25:272-281.
13. Gresa-Arribas N., Serratosa J., Saura J., Sola C. Inhibition of CCAAT/enhancer binding protein delta expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J.Neurochem. 2010, 115:526-536.
14. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W., Zhai P., Sufit R.L., Siddique T. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 1994, 264:1772-1775.
15. Hour T.C., Lai Y.L., Kuan C.I., Chou C.K., Wang J.M., Tu H.Y., Hu H.T., Lin C.S., Wu W.J., Pu Y.S., Sterneck E., Huang A.M. Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells. Biochem. Pharmacol. 2010, 80:325-334.
16. Hu H.M., Baer M., Williams S.C., Johnson P.F., Schwartz R.C. Redundancy of C/EBP alpha, -beta, and -delta in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J.Immunol. 1998, 160:2334-2342.
17. Kaltschmidt B., Widera D., Kaltschmidt C. Signaling via NF-kappaB in the nervous system. Biochim. Biophys. Acta 2005, 1745:287-299.
18. Kettenmann H., Hanisch U.K., Noda M., Verkhratsky A. Physiology of microglia. Physiol. Rev. 2011, 91:461-553.
19. Kim O.S., Park E.J., Joe E.H., Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J.Biol. Chem. 2002, 277:40594-40601.
20. Kolyada A.Y., Madias N.E. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells. Mol. Med. 2001, 7:329-343.
21. Kwon D., Fuller A.C., Palma J.P., Choi I.H., Kim B.S. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B. Glia 2004, 45:287-296.
22. Laflamme N., Rivest S. Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating gram-negative bacterial cell wall components. FASEB J. 2001, 15:155-163.
23. Li H., Gade P., Xiao W., Kalvakolanu D.V. The interferon signaling network and transcription factor C/EBP-beta. Cell. Mol. Immunol. 2007, 4:407-418.
24. Li N., Choudhuri S., Cherrington N.J., Klaassen C.D. Down-regulation of mouse organic anion-transporting polypeptide 4 (Oatp4; Oatp1b2; Slc21a10) mRNA by lipopolysaccharide through the toll-like receptor 4 (TLR4). Drug Metab. Dispos. 2004, 32:1265-1271.
25. Li R., Strohmeyer R., Liang Z., Lue L.F., Rogers J. CCAAT/enhancer binding protein delta (C/EBPdelta) expression and elevation in Alzheimer's disease. Neurobiol. Aging 2004, 25:991-999.
26. Litvak V., Ramsey S.A., Rust A.G., Zak D.E., Kennedy K.A., Lampano A.E., Nykter M., Shmulevich I., Aderem A. Function of C/EBPdelta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals. Nat. Immunol. 2009, 10:437-443.
27. Liu W., Tang Y., Feng J. Cross talk between activation of microglia and astrocytes in pathological conditions in the central nervous system. Life Sci. 2011, 89:141-146.
28. Liu Y.W., Tseng H.P., Chen L.C., Chen B.K., Chang W.C. Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein beta and delta in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages. J.Immunol. 2003, 171:821-828.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
30. Lu Y.C., Kim I., Lye E., Shen F., Suzuki N., Suzuki S., Gerondakis S., Akira S., Gaffen S.L., Yeh W.C., Ohashi P.S. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J.Immunol. 2009, 182:7212-7221.
31. Medzhitov R., Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 2009, 9:692-703.
32. Murray C.L., Skelly D.T., Cunningham C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6. J.Neuroinflammation 2011, 8:50.
33. Paglinawan R., Malipiero U., Schlapbach R., Frei K., Reith W., Fontana A. TGFbeta directs gene expression of activated microglia to an anti-inflammatory phenotype strongly focusing on chemokine genes and cell migratory genes. Glia 2003, 44:219-231.
34. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.
35. Philips T., Robberecht W. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol. 2011, 10:253-263.
36. Poli V. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J.Biol. Chem. 1998, 273:29279-29282.
37. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., Knapp D.J., Crews F.T. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
38. Ramberg V., Tracy L.M., Samuelsson M., Nilsson L.N., Iverfeldt K. The CCAAT/enhancer binding protein (C/EBP) delta is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-beta peptide. J.Neuroinflammation 2011, 8:34.
39. Ramji D.P., Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 2002, 365:561-575.
40. Ransohoff R.M., Liu L., Cardona A.E. Chemokines and chemokine receptors:multipurpose players in neuroinflammation. Int. Rev. Neurobiol. 2007, 82:187-204.
41. Saha R.N., Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal 2006, 8:929-947.
42. Samuelsson M., Ramberg V., Iverfeldt K. Alzheimer amyloid-beta peptides block the activation of C/EBPbeta and C/EBPdelta in glial cells. Biochem. Biophys. Res. Commun. 2008, 370:619-622.
43. Saura J., Tusell J.M., Serratosa J. High-yield isolation of murine microglia by mild trypsinization. Glia 2003, 44:183-189.
44. Sekine O., Nishio Y., Egawa K., Nakamura T., Maegawa H., Kashiwagi A. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J.Biol. Chem. 2002, 277:36631-36639.
45. Singh A.K., Jiang Y. How does peripheral lipopolysaccharide induce gene expression in the brain of rats?. Toxicology 2004, 201:197-207.
46. Sterneck E., Paylor R., Jackson-Lewis V., Libbey M., Przedborski S., Tessarollo L., Crawley J.N., Johnson P.F. Selectively enhanced contextual fearconditioning in mice lacking the transcriptional regulator CCAAT/enhancerbinding protein delta. Proc. Natl. Acad. Sci. U. S. A 1998, 95:10908-10913.
47. Straccia M., Gresa-Arribas N., Dentesano G., Ejarque-Ortiz A., Tusell J.M., Serratosa J., Sola C., Saura J. Pro-inflammatory gene expression and neurotoxic effects of activated microglia are attenuated by absence of CCAAT/enhancer binding protein beta. J.Neuroinflammation 2011, 8:156.
48. Tsai V.W., Mohammad M.G., Tolhurst O., Breit S.N., Sawchenko P.E., Brown D.A. CCAAT/enhancer binding protein-delta expression by dendritic cells regulates CNS autoimmune inflammatory disease. J.Neurosci. 2011, 31:17612-17621.
49. Tsukada J., Yoshida Y., Kominato Y., Auron P.E. The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation. Cytokine 2011, 54:6-19.
50. Valente T., Junyent F., Auladell C. Zac1 is expressed in progenitor/stem cells of the neuroectoderm and mesoderm during embryogenesis: differential phenotype of the Zac1-expressing cells during development. Dev. Dyn. 2005, 233:667-679.
51. Valente T., Mancera P., Tusell J.M., Serratosa J., Saura J. C/EBPbeta expression in activated microglia in amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:2186-2199.
52. Vargas M.R., Johnson J.A. The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 2009, 11:e17.
53. Weydt P., Yuen E.C., Ransom B.R., Moller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 2004, 48:179-182.
54. Wu K.K. Transcription-based COX-2 inhibition: a therapeutic strategy. Thromb. Haemost. 2006, 96:417-422.
55. Xiao J., Sun B., Cai G.P. Transient expression of interferon-inducible p204 in the early stage is required for adipogenesis in 3T3-L1 cells. Endocrinology 2010, 151:3141-3153.
56. Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S., Appel S.H. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J.Neurochem. 2007, 102:2008-2019.
57. Yan C., Zhu M., Staiger J., Johnson P.F., Gao H. C5a-regulated CCAAT/enhancer binding protein beta and -delta are essential in Fcgamma receptor- mediated inflammatory cytokine and chemokine production in macrophages. J.Biol. Chem. 2011, 287:3217-3230.
58. Yu X., Si J., Zhang Y., Dewille J.W. CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation. Cancer Cell Int. 2010, 10:48.
59. Yukawa K., Tanaka T., Tsuji S., Akira S. Expressions of CCAAT/Enhancer-binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J.Biol. Chem. 1998, 273:31345-31351.